Advancements in Cardiac Amyloidosis Treatment
Cardiac amyloidosis (CA) is a progressive condition resulting from the deposition of amyloid fibrils in the heart, which leads to severe diastolic dysfunction and restrictive cardiomyopathy. The disease has two main subtypes: light-chain and transthyretin (TTR) CA, with the latter subdivided into wi...
Saved in:
Main Authors: | Tarek Ziad Arabi, Abdullah Shaik, Ahmed El-Shaer, Omar Al Tamimi, Eman Nayaz Ahmed, Mohamad S. Alabdaljabar, Ahmad Safdar, Ali Mushtaq |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/13/1/79 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Cardiac Amyloidosis in Patients Undergoing Echocardiography at a Tertiary Center
by: Jonathan D. Knott, MD, et al.
Published: (2025-03-01) -
A case series of patients with cardiac amyloidosis evaluated at a Colombian university hospital
by: Juan David López-Ponce de León, et al.
Published: (2025-02-01) -
Cardiac Amyloidosis Masquerading as Hypertrophic Obstructive Cardiomyopathy: Co-existence or Coincidence?
by: Madhu Shukla, et al.
Published: (2024-07-01) -
Serum Biomarkers in Transthyretin Amyloidosis: An Overview of Neurofilaments, Cardiac, Renal, and Gastrointestinal Involvement
by: Valeria Guglielmino, et al.
Published: (2025-01-01) -
Assessing microvascular dysfunction and predicting long-term prognosis in patients with cardiac amyloidosis by cardiovascular magnetic resonance quantitative stress perfusion
by: Leting Tang, et al.
Published: (2025-01-01)